Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 
How the UK’s rollback of banking regulations could risk another financial crisis 
Delta Flight Makes Emergency Landing in Atlanta After Cockpit Fumes Reported 
DeepSeek to Raise AI API Prices as Demand for New Models Surges 
Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium 
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins 
KiwiSaver shakeup: private asset investment has risks that could outweigh the rewards 
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook 
Elliott Investment Management Takes Significant Stake in BP to Push for Value Growth 
UK Markets Face Rising Volatility as Hedge Funds Target Pound and Gilts 
Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised 
U.S. Banks Report Strong Q4 Profits Amid Investment Banking Surge 
OpenAI Restricts Astra AI Over Cyberattack Risks 
U.S. Condemns China's Dominance in Global Shipbuilding and Maritime Sectors 
Gold is meant to be a ‘safe haven’ in uncertain times. Why is it crashing amid a war? 
U.S. Stock Futures Rise as Trump Takes Office, Corporate Earnings Awaited 
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations 
Infosys shares fell nearly 6% on Friday, marking their largest one-day decline since July 2023. The drop followed concerns raised by analysts over the quality of earnings in its third-quarter report. By 11:49 a.m. IST, Infosys shares were down 5.7%, weighing heavily on both the Nifty IT index and the benchmark Nifty 50, which declined 2.5% and 0.7%, respectively. Its U.S.-listed shares also dipped about 6% overnight.
The company raised its annual revenue forecast for the third time this financial year, driven by increased spending from U.S. banking and retail clients on discretionary projects. This mirrors trends seen in competitors Tata Consultancy Services and HCLTech. Despite the optimistic outlook, analysts expressed concerns about the reliance on "third-party items" in Infosys' deal pipeline, which cast doubts on the quality of the reported earnings beat.
Morgan Stanley noted that commentary around small deal pipelines showed no significant improvement, suggesting a gradual industry recovery. Small deals account for over two-thirds of Infosys' total deal intake, according to BofA Global Research. Markets now seek concrete signs of increased discretionary spending rather than optimistic commentary from IT firms.
Infosys shares have risen 22.5% in 2024, outperforming Tata Consultancy Services and LTIMindtree, but trailing HCLTech, which gained 31%. The earnings report, while positive on paper, has sparked debate on whether revenue growth is sustainable, given the current market dynamics.
